Angioedema
also: Angiedema
17 drugs1,896 FAERS reportsMedDRA PT
GET
/api/v1/reaction/angioedemaReference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. The drugs below are ranked by how often this reaction appears on FAERS reports for each drug — high share does not mean the drug caused the reaction, and absence from this list does not mean the reaction never occurred. This is not a symptom checker.
DefinitionNLM MeSH D000799
Swelling involving the deep DERMIS, subcutaneous, or submucosal tissues, representing localized EDEMA. Angioedema often occurs in the face, lips, tongue, and larynx.
Source: U.S. National Library of Medicine — MeSH (Angioedema)
Drugs reporting Angioedema (17)
Share = reports listing this reaction ÷ total matched reports for the drug. — means the upstream totals query failed at ingest and the denominator is unknown.
- 1Frovatriptan18125%
- 2Estriol36121%
- 3Ethacrynate117%
- 4Danazol2278.2%
- 5Tenecteplase1167.7%
- 6Flurbiprofen895.8%
- 7Methacholine45.6%
- 8Enalaprilat135.3%
- 9Calcium Hydroxide15.3%
- 10Alteplase6204.2%
- 11Remibrutinib213.7%
- 12Thallium13.3%
- 13Eflornithine12.8%
- 14Zolmitriptan1922.7%
- 15Iothalamate22.4%
- 16Sugammadex461.8%
- 17Iomeprol201.6%
Related reactions
Other reactions most often co-reported on the same drug set. Ranked by Jaccard similarity over drug-id sets — pure data-derived co-occurrence, not a clinical relationship.
- Swollen Tongue3 shared · 0.14
- Haemorrhagic Transformation Stroke2 shared · 0.11
- Neurological Decompensation2 shared · 0.11
- Dysphonia3 shared · 0.09
- Swelling Face3 shared · 0.09
- Haemorrhage Intracranial2 shared · 0.08
- Aphasia2 shared · 0.08
- Bronchitis2 shared · 0.07
- Medication Error2 shared · 0.07
- Bronchospasm2 shared · 0.07
Literature
Recent PubMed references pinned to Angioedema as a MeSH major topic. About the reaction term itself — not about any specific drug.
- [Angioedema 2025 - Advancements in Diagnosis and Treatment].Harefuah · 2026 · Reshef A, Agmon Levin N, Ben Or S, et al.PMID 42200329
- Probiotic supplementation to mitigate berotralstat gastrointestinal side effects: a multicenter case series from the ITACA network.Frontiers in immunology · 2026 · Gidaro A, Guarino MD, Arcoleo F, et al.PMID 42136670DOI 10.3389/fimmu.2026.1790199
- Lanadelumab safety, efficacy, and pharmacokinetics in patients aged ≥12 with hereditary angioedema in China: an open-label, multicenter study.Frontiers in immunology · 2026 · Zhi Y, Zhu R, Sun Y, et al.PMID 42136633DOI 10.3389/fimmu.2026.1750735
- Quality of Life and Socioeconomic Situation of Patients with Hereditary Angioedema in Slovakia.Medicina (Kaunas, Lithuania) · 2026 · Ondrušová M, Suchanský M, Svidová SV, et al.PMID 42075577DOI 10.3390/medicina62040705
- Monoclonal antibodies in the management of hereditary angioedema.Expert opinion on biological therapy · 2026 · Farkas H, Voloncs-Mindszenthy L, Horváth HR, et al.PMID 42048581DOI 10.1080/14712598.2026.2664733
- Hemophilia and hereditary angioedema: parallel therapeutic advances in genetic diseases of serine protease pathways.Research and practice in thrombosis and haemostasis · 2026 · Cugno M, Mannucci PMPMID 42023397DOI 10.1016/j.rpth.2026.103456
Note. FAERS reports are voluntarily submitted and are NOT incidence rates, signals, or causal evidence. Counts reflect reporting volume, not how often a reaction occurs. Reference statistics only.